Legacy Receives New York State CLEP Approval for Two Laboratory-Developed Tests.
Legacy, a leading male fertility testing and sperm analysis company, has just received approval from the New York State Clinical Laboratory Evaluation Program (CLEP) for two laboratory-developed tests: semen analysis and DNA fragmentation analysis.
These tests are designed to help men and couples struggling with infertility issues. Semen analysis, also known as semen inspection, examines the quality and quantity of a man’s semen. DNA fragmentation analysis, on the other hand, measures the amount of damaged DNA in a man’s sperm, which can affect fertility.
What This Means
What this means is that Legacy’s tests can now be used in New York State to help men and couples seeking fertility treatment. This approval is significant because it’s a major step towards making these tests more accessible to those who need them. For men experiencing fertility issues, getting a semen analysis or DNA fragmentation analysis can be a game-changer.
Legacy’s Laboratory-Developed Tests
Legacy’s laboratory-developed tests are designed to provide accurate and reliable results for patients struggling with male infertility. Their semen analysis test examines various parameters such as sperm count, motility, and morphology. The DNA fragmentation analysis test, on the other hand, uses specialized technology to measure the amount of damaged DNA in a man’s sperm.
Legacy’s tests have been designed to provide valuable insights into the underlying causes of male infertility. By identifying the root causes of fertility issues, Legacy’s tests can help men and couples make informed decisions about their reproductive health.
New York State’s CLEP Approval Process
The New York State CLEP approval process is notoriously stringent, with a rigorous review of laboratory-developed tests to ensure their safety and efficacy. This approval is a testament to Legacy’s commitment to quality and innovation in laboratory-developed testing. With this approval, Legacy’s tests can now be used in New York State, providing men and couples with more options for fertility testing and treatment.
